Varaico: Literature-Extracted Genetic Variants

Gene:GLA
Variant:p.Q321*
Back to variants list

GLA

NM_000169.3:p.Q321*

Associated Papers

Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development.

Li S et al.

Biomolecules, 2023

37371567 (PubMed )
Supplement: biomolecules-13-00988-s001.zip › biomolecules-2391899-supplementary.xlsx › Sheet1

Molecular spectrum of inherited FVII deficiency in North India revealed a recurrent variant with a founder effect.

Sharma R et al.

Haemophilia : the Official Journal of the World Federation of Hemophilia, 2023

Dosage Compensation in Females with X-Linked Metabolic Disorders.

Juchniewicz P et al.

International Journal of Molecular Sciences, 2021

33925963 (PubMed )
Supplement: ijms-22-04514-s001.zip › Supplementary_File_Table_S3.pdf

Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants.

Lombardi S et al.

Rna Biology, 2020

Mutation spectrum of α-Galactosidase gene in Japanese patients with Fabry disease.

Kobayashi M et al.

Journal of Human Genetics, 2019

Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease.

Lenders M et al.

Orphanet Journal of Rare Diseases, 2016

Disease manifestations and X inactivation in heterozygous females with Fabry disease.

Maier EM et al.

Acta Paediatrica (oslo, Norway : 1992). Supplement, 2006

Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease.

Schäfer E et al.

Human Mutation, 2005

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."